Kingdon Capital Management’s Immunomedics Inc IMMU Stock Holding History

Kingdon Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-71,400	Closed	-$6.07M	–	80
2020 Q3	$6.07M	Buy	+71,400	New	+$3.61M	0.68%	44

Kingdon Capital Management's IMMU Position: Q4 2020 in Review

Kingdon Capital Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 71,400 shares — an estimated $6.07M sold.

Kingdon Capital Management first reported a position in IMMU in Q3 2020 and held it in 1 quarter. The position peaked at $6.07M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Kingdon Capital Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Kingdon Capital Management sold 71,400 Immunomedics Inc shares in Q4 2020, an estimated $6.07M.
Kingdon Capital Management first reported a position in Immunomedics Inc in Q3 2020 and held it in 1 quarter.
Kingdon Capital Management's Immunomedics Inc position peaked at $6.07M in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Kingdon Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.